MYLAN 2264 Pill — BLACK;PURPLE CAPSULE, 14mm — Terazosin

No photo available

Imprint	MYLAN / 2264
Colour	BLACK;PURPLE
Shape	CAPSULE
Size	14
Strength	TERAZOSIN HYDROCHLORIDE ANHYDROUS 2 mg
Dosage form	Capsule
Manufacturer	PD-Rx Pharmaceuticals, Inc.
NDC	43063-495
Schedule	—
Availability	—
Ingredients	TERAZOSIN HYDROCHLORIDE ANHYDROUS[TERAZOSIN]

What does this imprint mean?

The imprint "MYLAN 2264" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Terazosin

Uses and warnings

No boxed warning. Contraindicated in patients "known to be hypersensitive to terazosin hydrochloride." The label highlights "first-dose" postural hypotension and syncope, which "can cause marked lowering of blood pressure, especially postural hypotension," most common with the initial dose or dose increases - therapy should start at a low dose given at bedtime. Also warns of rare priapism ("painful penile erection, sustained for hours") that can cause permanent impotence if not treated promptly, and Intraoperative Floppy Iris Syndrome observed during cataract surgery in patients taking alpha-1 blockers.

Indicated for "treatment of symptomatic benign prostatic hyperplasia (BPH)," with approximately 70% of patients experiencing "an increase in urinary flow and improvement in symptoms," and for "treatment of hypertension," where it "can be used alone or in combination with other antihypertensive agents."

Read the full drug profile →